Membrane lipid replacement

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Membrane Lipid Replacement or MLR.

Notable studies[edit | edit source]

  • 2017, Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues[1] (Full text)

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]